Pronase used for the treatment of diseases of the liver and kidneys in humans and animals
US4485095A · kind A · utility
25Cited by
5References
3Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Aug 6, 1982 |
| Grant date | Nov 27, 1984 |
| Priority date | — |
| Expiry date | Aug 6, 2002 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12Y304/21081
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Diseases of the liver and kidneys in humans and animals may be prevented and treated by administering a therapeutically effective amount of a member selected from the group consisting of one or more proteolytic enzymes, one or more polysaccharide mucopolysaccharide-lysing enzymes, and mixtures thereof, in combination with a pharmaceutically acceptable carrier.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.